Cytotheryx
Rochester, Minnesota, United States · Biotechnology, Health Care · 18 employees
Cytotheryx is a platform technology company focused on the development of a high-quality, consistent source of primary human hepatocytes (PHH), the functional cells of the liver. Based in Rochester, Minnesota, Cytotheryx is using innovative technology to increase the supply of available cells for use by pharmaceutical companies, biotechnology companies, and academic research institutions. Prim
Funding history
- Series series a — $60.0M — Jan 2026
Recent signals
- Jan 12, 2026: Raised $60.0M in Series series a
See plans & pricing → Track Cytotheryx’s funding, hiring, and signals — with verified contacts — on Fundz.